X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES MERCK LTD ALKEM LABORATORIES/
MERCK LTD
 
P/E (TTM) x - 27.3 - View Chart
P/BV x 6.1 3.1 200.2% View Chart
Dividend Yield % 0.7 0.9 76.5%  

Financials

 ALKEM LABORATORIES   MERCK LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MERCK LTD
Dec-16
ALKEM LABORATORIES/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,060 149.9%   
Low Rs1,232623 197.8%   
Sales per share (Unadj.) Rs417.5632.4 66.0%  
Earnings per share (Unadj.) Rs56.345.7 123.1%  
Cash flow per share (Unadj.) Rs64.762.3 103.8%  
Dividends per share (Unadj.) Rs12.7011.00 115.5%  
Dividend yield (eoy) %0.91.3 68.9%  
Book value per share (Unadj.) Rs292.9388.8 75.3%  
Shares outstanding (eoy) m119.5716.60 720.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.3 253.9%   
Avg P/E ratio x25.118.4 136.1%  
P/CF ratio (eoy) x21.813.5 161.4%  
Price / Book Value ratio x4.82.2 222.5%  
Dividend payout %22.624.1 93.8%   
Avg Mkt Cap Rs m168,65313,969 1,207.3%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m9,1711,487 616.9%   
Avg. sales/employee Rs ThNM6,631.9-  
Avg. wages/employee Rs ThNM939.2-  
Avg. net profit/employee Rs ThNM479.4-  
INCOME DATA
Net Sales Rs m49,91510,498 475.5%  
Other income Rs m1,645242 678.7%   
Total revenues Rs m51,56110,741 480.0%   
Gross profit Rs m8,4821,135 747.1%  
Depreciation Rs m1,006276 365.1%   
Interest Rs m6710-   
Profit before tax Rs m8,4511,102 766.7%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606343 467.8%   
Profit after tax Rs m6,731759 887.0%  
Gross profit margin %17.010.8 157.1%  
Effective tax rate %19.031.1 61.0%   
Net profit margin %13.57.2 186.5%  
BALANCE SHEET DATA
Current assets Rs m27,0626,410 422.2%   
Current liabilities Rs m15,3248,828 173.6%   
Net working cap to sales %23.5-23.0 -102.1%  
Current ratio x1.80.7 243.2%  
Inventory Days Days6758 115.3%  
Debtors Days Days4138 107.5%  
Net fixed assets Rs m12,6101,406 896.6%   
Share capital Rs m239166 144.0%   
"Free" reserves Rs m34,4906,286 548.7%   
Net worth Rs m35,0276,455 542.7%   
Long term debt Rs m1,2120-   
Total assets Rs m54,3878,828 616.0%  
Interest coverage x13.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.2 77.2%   
Return on assets %13.68.6 158.3%  
Return on equity %19.211.8 163.4%  
Return on capital %24.917.1 145.6%  
Exports to sales %12.98.3 156.3%   
Imports to sales %3.121.0 14.7%   
Exports (fob) Rs m6,461869 743.2%   
Imports (cif) Rs m1,5402,209 69.7%   
Fx inflow Rs m6,563959 684.5%   
Fx outflow Rs m3,0122,612 115.3%   
Net fx Rs m3,552-1,653 -214.8%   
CASH FLOW
From Operations Rs m7,2591,070 678.1%  
From Investments Rs m1,864-750 -248.7%  
From Financial Activity Rs m-9,273-150 6,190.1%  
Net Cashflow Rs m-150171 -87.8%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 33.1 18.2 181.9%  
FIIs % 0.0 1.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 29.1 -  
Shareholders   68,381 28,591 239.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  NOVARTIS  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 24, 2017 12:33 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS